Showing results (1-10 of 540) with videos related to
Sort By:
Pageof 54
JAMA Oncology|April 22, 2016
Prognostic and Predictive Value in KRAS in Non-Small-Cell Lung Cancer: A ReviewKevin Wood, Thomas Hensing, Raeva Malik, et al.Advances in Experimental Medicine and Biology|December 3, 2013
A personalized treatment for lung cancer: molecular pathways, targeted therapies, and genomic characterizationThomas Hensing, Apoorva Chawla, Rishi Batra, et al.Expert Opinion on Drug Safety|February 10, 2015
A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patientsAlana Dikopf, Kevin Wood, Ravi SalgiaAmerican Journal of Clinical Oncology|June 28, 2017
Capecitabine and Celecoxib as a Promising Therapy for Thymic NeoplasmsKevin Wood, Elizabeth Byron, Linda Janisch, et al.Oncotarget|April 12, 2014
Molecular pathways and therapeutic targets in lung cancerEmma Shtivelman, Thomas Hensing, George R Simon, et al.Seminars in Oncology|March 23, 2011
Personalized treatment of lung cancerRavi Salgia, Thomas Hensing, Nicholas Campbell, et al.Cancer Medicine|April 9, 2014
Fibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumorsRavi SalgiaMolecular Cancer Therapeutics|April 5, 2017
MET in Lung Cancer: Biomarker Selection Based on Scientific RationaleRavi SalgiaExpert Review of Molecular Diagnostics|May 4, 2016
Mutation testing for directing upfront targeted therapy and post-progression combination therapy strategies in lung adenocarcinomaRavi SalgiaPageof 54